How to Track a Retatrutide or Tirzepatide Microdose

"Microdosing" retatrutide or tirzepatide — using amounts well below a standard prescribed dose — has become a common talking point in peptide communities, often framed as a way to reduce side effects or stretch a vial further. Whatever the reasoning, the practical problem is the same: you are now working with volumes small enough that ordinary measurement error stops being a rounding footnote and starts being a meaningful chunk of the dose itself. Tracking has to get more precise, not less, as the numbers get smaller.

Why small volumes punish sloppy tracking

A standard insulin syringe is marked in whole or half units out of 100. At a dose that fills 40-50 units, misreading the plunger by a unit is a small percentage error. At a dose that fills 3-5 units, that same one-unit misread is a 20-30% swing in what actually went in. The syringe did not get less accurate — the dose just got small enough that the syringe's normal margin of error now matters.

The same thing happens on the reconstitution side. If you mix a vial with more or less BAC water than your log says, every draw calculated from that concentration is off by the same percentage, and the error is invisible until something doesn't add up weeks later. The free reconstitution calculator does this math in mL and syringe units so you are working from a number, not a guess, but the number is only as good as the inputs you logged when you mixed the vial.

What to log every time

The mix and the draw

• Vial size and the exact BAC water volume used to reconstitute it — this sets your concentration for every draw that follows.
• Concentration (mg/mL), calculated once and reused rather than re-estimated from memory each time.
• Units drawn on the syringe for this specific dose, not just the mg target.
• Date and time of the injection, and the injection site, rotated as usual.

The response

• Weight, on a consistent weekly cadence.
• Appetite and GI symptoms — often the first thing people are trying to reduce by going smaller, so it is worth tracking directly rather than assuming.
• Energy, sleep, and mood, since side effects at low doses can be subtle enough that only a log catches the pattern.
• How the vial is lasting — inventory matters more here since a microdose protocol often means many more draws from the same vial over a longer window.

Retatrutide in particular is a research compound with a short track record outside clinical trials, which makes consistent logging even more important — if something feels off, a precise record of what was actually drawn and when is the first thing worth reviewing, and the first thing a clinician will ask about.

Reading the trend at low doses

Smaller doses tend to produce smaller, slower signals, which means the usual advice applies with more force: judge the trend over several weeks, not the day-to-day number. A single weigh-in or a single rough day tells you very little. What tells you something is a weight or appetite trend plotted against a dose history that you can trust — which only exists if the units drawn were logged accurately in the first place, not reconstructed afterward from memory.

Common mistakes

• Eyeballing the draw instead of calculating it. At microdose volumes, "about that line" is not precise enough to be useful data later.
• Re-estimating concentration from memory. Log the mix once, in writing, and reuse that number for every draw from that vial.
• Treating a single data point as an answer. One good or bad day at a small dose is noise; the trend over weeks is the signal.
• Skipping the side-effect log because the dose is "small." Side effects are exactly what most people are trying to measure by going smaller — track them directly instead of assuming the smaller number worked.

The bottom line

Smaller doses do not mean looser tracking — they mean the opposite. Log the exact reconstitution, the exact units drawn, and the response every time, read the trend over weeks, and talk to a clinician about anything you are not sure about. For more on the broader approach, see our guide on how to tell if a peptide is actually working and the comparison of peptide tracker apps if you are deciding what to use.

Frequently asked questions